- Snow Shoveling, Slips on Ice Bring Cold Weather Dangers
- How Moving the Homeless to Hotels During the Pandemic Helps Everyone
- With 3 COVID Vaccines Approved, Is There a ‘Best’ Shot?
- It’s Too Soon to Lift COVID Restrictions: Fauci
- Health Highlights: March 5, 2021
- AHA News: Why Did Yankees Manager Get a Pacemaker, and How Does It Work?
- When Facebook, Twitter Flag Posts as ‘Unverified,’ Readers Listen
- Lockdowns Tied to Temporary Drops in Illicit Drug Seizures
- Formaldehyde in Hair Straighteners Prompts FDA Warning
- Big Paychecks Pay Off in Self-Confidence, Study Finds
Clinical Trials Update: Nov. 3, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Hepatitis C
This study is for people with chronic hepatitis C, genotype 1. You must have had a liver biopsy less than 24 months ago without evidence of cirrhosis to qualify.
The research site is in Tamarac, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/hepatitis.aspx.
—–
Gout
This study will evaluate the cardiovascular safety of febuxostat and allopurinol in people with gout and cardiovascular disease. Participants receive study medication and related medical care at no cost, and compensation for time and travel.
The research site is in Houston, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.
—–
Psoriasis
This study will evaluate the safety and tolerability of an investigational drug for moderate-to-severe chronic plaque psoriasis.
The research site is in Winston-Salem, N.C.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/psoriasis.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
